Repligen Corporation ( RGEN) - Key Metrics

RGEN Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q1 ? ? ? ?
2025Q4 $3.50 $0.24 $0.45 $0.30
2025Q3 $3.36 $0.27 $0.86 $0.76
2025Q2 $3.25 $0.26 $0.51 $0.37
2025Q1 $3.01 $0.10 $0.27 $0.19

RGEN Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q1 ? ?
2025Q4 ? 174.26
2025Q3 ? 125.97
2025Q2 ? 117.51
2025Q1 ? 306.22

RGEN Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q1 0.35% ?
2025Q4 0.18% ?
2025Q3 0.57% ?
2025Q2 0.30% ?
2025Q1 0.15% ?

RGEN

Price: $122.77

52 week price:
100.99
175.77

Earnings Per Share: 0.91 USD

P/E Ratio: 127.37

Exchange: NMS

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 633600

Ebitda: 2.7 million

Market Capitalization: 6.9 billion

Links: